SYRA
Syra Health Corp. Class A Common Stock
NASDAQ: SYRA · HEALTHCARE · MEDICAL CARE FACILITIES
$0.52
+22.64% today
Updated 2026-04-29
Market cap
$5.06M
P/E ratio
—
P/S ratio
0.70x
EPS (TTM)
$-0.08
Dividend yield
—
52W range
$0 – $1
Volume
0.1M
Syra Health Corp. Class A Common Stock (SYRA) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $1.41M | $5.62M | $5.52M | $7.98M | $7.23M |
| Revenue growth (YoY) | — | — | +298.4% | -1.8% | +44.7% | -9.5% |
| Cost of revenue | — | $979622.00 | $4.56M | $4.11M | $6.33M | $4.74M |
| Gross profit | — | $430354.00 | $1.06M | $1.41M | $1.65M | $2.49M |
| Gross margin | — | 30.5% | 18.9% | 25.5% | 20.7% | 34.4% |
| R&D | — | — | $0.00 | $240048.00 | $585146.00 | $67840.00 |
| SG&A | — | $416009.00 | $3.11M | $4.01M | $4.77M | $3.30M |
| Operating income | $-4267.00 | $-3280.00 | $-2.09M | $-2.89M | $-3.76M | $-904324.00 |
| Operating margin | — | -0.2% | -37.2% | -52.4% | -47.2% | -12.5% |
| EBITDA | $-4267.00 | $-3073.00 | $-2.07M | $-2.84M | $-3.68M | $-883856.00 |
| EBITDA margin | — | -0.2% | -36.9% | -51.4% | -46.1% | -12.2% |
| EBIT | $-4267.00 | $-3280.00 | $-2.09M | $-2.88M | $-3.74M | $-904324.00 |
| Interest expense | — | $0.00 | $28533.00 | $53686.00 | $15600.00 | $13270.00 |
| Income tax | $-51204.00 | — | $63.00 | $2942.00 | $-3.76M | — |
| Effective tax rate | 92.3% | 0.0% | -0.0% | -0.1% | 50.0% | 0.0% |
| Net income | $-4267.00 | $-3280.00 | $-2.12M | $-2.94M | $-3.76M | $-896333.00 |
| Net income growth (YoY) | — | +23.1% | -64478.2% | -38.7% | -27.9% | +76.2% |
| Profit margin | — | -0.2% | -37.7% | -53.3% | -47.1% | -12.4% |